Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
If you have a loved one living with Alzheimer's disease, winter can be a difficult season to navigate. Here are some ways to ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
My weight concerns mainly injure my considerable vanity, and I’m not about to outsource my self-esteem issue to Big Pharma if ...
The explosive rise of GLP-1 drugs like Ozempic has brought an accompanying challenge: logistics too knotty for a single ...
Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...
For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.
Ozempic, Wegovy and Mounjaro may offer serious health benefits beyond weight loss. The GLP-1 medications have been linked to decreased risks of heart disease, kidney disease and Alzheimer’s ...